ReSound OMNIA miniRIE vs Resound Vivia 9 60S microRIE

The ReSound OMNIA miniRIE is a premium behind-the-ear prescription hearing aid released in 2022, priced at $4,764. In our lab testing, it earned an A grade with a SoundScore of 4.0/5, ranking #24 of 36 devices in the Prescription Hearing Aid category. This device demonstrates solid performance in speech clarity for quiet environments, scoring 3.7/5—0.34 points above the category average. However, speech understanding in noisy situations is a notable weakness, with a score of just 1.0/5, falling 0.96 points below the category average. This contrast suggests the OMNIA miniRIE performs best for users who primarily need support in calmer listening environments rather than challenging acoustic situations like busy restaurants or crowded gatherings. Feedback handling is strong at 4.1/5 in absolute terms, though it sits 0.61 points below the category average of 4.71/5. Own-voice comfort scores 2.9/5, slightly above average but mixed in absolute terms. Music streaming performance is similarly positioned at 2.7/5—essentially at the category average. The OMNIA miniRIE features rechargeable batteries, iPhone and Android streaming capability, and hands-free functionality. It has received the Expert's Choice Award in both 2023 and 2024. At this premium price point, buyers should be aware that several same-price competitors like the Phonak Sphere Infinio and Oticon Intent offer higher overall scores in our testing. This device may suit users prioritizing quiet-environment speech clarity and brand-specific features over maximum performance in noise.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.